Building a Patient-Centric Corporate Culture Based on Patient Engagement with Keri Yale Boehringer Ingelheim Pharmaceuticals TRANSCRIPT
Download PDFDec 7, 2022
Keri Yale, Head of Patient Centricity and Engagement at Boehringer Ingelheim Pharmaceuticals, brings a deep understanding of the need for pharmaceutical companies to be patient-centric in their culture and focus, including all the employees who do not deal directly with patients. Patient engagement is defined as engaging and listening to patients while integrating their input into the design of clinical trials and developing products and resources for patients and doctors.
Keri elaborates, "I was just thinking recently about how much the work that I've done over the past two decades has come full circle to the work that I just mentioned that I do today. I started at BI in sales. I was working in Los Angeles, and it was the height of the AIDS epidemic. I was calling on AIDS service organizations because we had HIV/AIDS medications, and I was meeting a number of people who were truly inspirational. One of those people who inspired me the most was the director at the time of an organization called Being Alive. And he was the first of many advocates that taught me how much I didn't know."
"We knew there were pockets of excellence, and we knew there were a number of people working in this way, but we wanted to make it across all employees, even those working in IT or HR or finance. We set up an approach where each leader is responsible for having a patient-centricity plan. These plans identify objectives and activities, and they should look very different because we want them to be authentic to the nature of their work. I think it also shows that our leadership recognizes that being patient-focused is everyone's job."
@boehringerus #BoehringerIngelheim #PatientEngagement #PatientCentricity #PatientInput #PatientAmbassador #PatientPartner
